A powerful transformation in healthcare robotics has reached an inflection point, driven by an aging global population, a shortage of skilled surgeons and clinical staff, and the push for minimally invasive procedures. For investors, broad robotics exchange-traded funds (ETFs) have expanded their allocation to med-tech innovators. Key healthcare stocks include Intuitive Surgical, whose da Vinci procedures rose approximately 16% year over year in the first quarter of 2026, with an installed base of 11,395 systems as of March 31, 2026, reflecting an increase of 12%. Illumina developed robotic systems like the Infinium Automated Pipetting System and Digital Microfluidics to automate sample preparation. Stryker is a leader in orthopedic robotics with its Mako system for robotic-arm assisted joint replacements.